Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitant.

Bayati, Samaneh

Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitant. [electronic resource] - Anti-cancer drugs 03 2018 - 243-252 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1473-5741

10.1097/CAD.0000000000000591 doi


Aprepitant
Cell Line, Tumor
Hematologic Neoplasms--drug therapy
Humans
Morpholines--pharmacology
Neurokinin-1 Receptor Antagonists--pharmacology
Receptors, Neurokinin-1--metabolism